Anti-Müllerian Hormone (AMH) is a hormone secreted by the granulosa cells in the ovarian follicles. It is a marker used to assess ovarian reserve, which refers to the quantity and quality of a woman’s remaining eggs. AMH levels tend to correlate with the number of remaining primordial follicles in the ovaries and can help predict a woman’s response to ovarian stimulation during fertility treatments.

High levels of AMH are generally associated with a larger number of remaining eggs and thus a higher ovarian reserve, which may suggest a good response to ovarian stimulation and potentially better chances of success with treatments such as in vitro fertilization (IVF). Conversely, low levels of AMH may indicate a diminished ovarian reserve, which could mean a decreased response to fertility treatments and lower chances of achieving pregnancy.

AMH levels are just one of the factors considered when assessing fertility potential, and individual responses to treatment can vary. Ultimately, the interpretation of AMH levels should be done in conjunction with a comprehensive fertility evaluation by a reproductive endocrinologist or fertility specialist to determine the best treatment plan and manage expectations regarding success rates.

It’s important to note that while AMH levels can provide valuable insights into ovarian reserve, they are not the sole determinant of fertility potential. Other factors such as age, overall health, and previous reproductive history also play important roles in fertility assessment and treatment planning.